Clinical pharmacist’s role in implementing a smoking cessation intervention in a Swiss regional hospital: an exploratory study

Dobrinas, Maria; Blanc, Anne-Laure; Rouiller, François; Christen, Grégoire; Coronado, Marcos; Tagan, Damien; Schäli, C.

doi:10.1007/s11096-014-9927-8

Cited by 14 publications

(10 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 26 Awareness about existing tobacco policies might influence the effectiveness of this group of health professionals as advocates for the support of smoke-free policies in Nigeria. 21 Relevant programs to increase awareness about existing tobacco control laws will be beneficial to pharmacists. Their current lack of knowledge about existing tobacco control laws within their environment may need to be addressed in designing these programs.…”

Section: Discussionmentioning

confidence: 99%

“…Existing studies on pharmacists in tobacco control research have focused on their role in providing tobacco cessation services largely ignoring their possible roles in promoting policy. 20 , 21 Pharmacists’ knowledge of tobacco and their attitudes towards smoke-free policies may influence their role as advocates for smoke-free policies within their communities. However, literature is sparse on the knowledge of health-related effects of tobacco and the attitudes towards smoke-free policies among pharmacists in Nigeria.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Tobacco related knowledge and support for smoke-free policies among community pharmacists in Lagos state, Nigeria

Poluyi¹,

Odukoya²,

Aina³

et al. 2015

Pharm Pract (Granada)

View full text Add to dashboard Cite

*Background: There are no safe levels of exposure to second hand smoke and smoke-free policies are effective in reducing the burden of tobacco-related diseases and death. Pharmacists, as a unique group of health professionals, might be able to play a role in the promotion of smoke-free policies. Objective: To determine the tobacco-related knowledge of community pharmacists and assess their support for smoke-free policies in Lagos state, Nigeria. Methods: A cross-sectional descriptive study design using both quantitative and qualitative methods was employed. Two hundred and twelve randomly selected community pharmacists were surveyed using a pre-tested selfadministered questionnaire. In addition, one focus group discussion was conducted with ten members of the Lagos state branch of the Association of Community Pharmacists of Nigeria. Results: The quantitative survey revealed that the majority (72.1%) of the respondents were aged between 20 and 40 years, predominantly male (60.8%), Yoruba (50.2%) or Igbo (40.3%) ethnicity and had been practicing pharmacy for ten years or less (72.2%). A majority (90.1%) of respondents were aware that tobacco is harmful to health. Slightly less (75.8%) were aware that second hand smoke is harmful to health. Among the listed diseases, pharmacists responded that lung (84.4%) and esophageal (68.9%) cancers were the most common diseases associated with tobacco use. Less than half of those surveyed associated tobacco use with heart disease (46.9%), chronic obstructive pulmonary disease (27.8%), bladder cancer (47.2%), peripheral vascular disease (35.8%) and sudden death (31.1%). Only 51.9% had heard of the World Health Organization Framework Convention on Tobacco Control (WHO FCTC). A little over half of the respondents (53.8%) were aware of any law in Nigeria controlling tobacco use. The majority of respondents supported a ban on smoking in homes (83.5%), in public places (79.2%), and in restaurants, nightclubs and bars (73.6%). For every additional client attended to daily, knowledge scores increased by 0.022 points. Current smokers were 1.3 times less likely to support smoke-free policies compared with non-smokers. reinforced the fact that the pharmacists were in support of smoke-free policies particularly in homes and public places. It also demonstrated that most of them were aware of the health risks associated with tobacco use and second hand smoke however some misconceptions seemed to exist. Conclusion: The pharmacists surveyed expressed support of smoke-free policies and most of them were aware of the health risks associated with tobacco use. However, awareness of WHO FCTC and country-level tobacco legislation was low. Current smokers were less likely to support smoke-free policies. Community pharmacists should therefore be considered worth engaging for the promotion of smoke-free policies. Efforts should also be made to educate pharmacists about country level smoke-free laws.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Tobacco related knowledge and support for smoke-free policies among community pharmacists in Lagos state, Nigeria

Poluyi¹,

Odukoya²,

Aina³

et al. 2015

Pharm Pract (Granada)

View full text Add to dashboard Cite

show abstract

“…The authors concluded that moderate-intensity smoking cessation intervention from a pharmacist in the hospital led to a higher quit rate than those reported in control groups of other studies. Additionally, readiness to quit improved one month after discharge supporting the role of the pharmacist in tobacco cessation interventions [6]. Lastly, an ongoing study by Thomas et al is focusing on a pharmacist-led intervention program in the hospital environment.…”

Section: Impact Of a Pilot Pharmacy-led Tobacco Cessation Medicationmentioning

confidence: 92%

Impact of a Pilot, Pharmacy-Led Tobacco Cessation Medication Protocol at Discharge in a Community Hospital

McKenzie¹,

Patel²,

Eder³

2017

JPP

View full text Add to dashboard Cite

Purpose: To evaluate the implementation of a pharmacy-led tobacco cessation medication education protocol at discharge in a community hospital. Design: Single center, retrospective quality assessment study. Methods: A retrospective review of a pharmacy-led protocol was completed from November 2016 through April 2017. Data from one year prior to implementation of the protocol was analyzed against the study group. Results: A total of 607 tobacco cessation medication education interventions were made during the study period, 379 patients (62.4%) were given an OTC (Over The Counter) NRT (Nicotine Replacement Therapy) recommendation upon discharge and 148 (24.4%) were referred to the Ohio Tobacco Quit Line. TJC (The Joint Commission) TOB-3/3a measure was met in 44.1% of patients during the study period compared to 0% in the comparator group. Of the 75 patients who were reached via follow-up phone call, 23 (30.7%) purchased an OTC NRT and 22 (29.3%) completely quit using tobacco. Conclusions: Pharmacy-led tobacco cessation interventions during hospitalizations have a positive impact on TJC TOB-3/3a quality measure results and quit rates post-discharge. Our results encourage future studies in this area to further establish the importance of pharmacist involvement in tobacco cessation, specifically in the hospital setting.

show abstract

“…103 Prescription smoking cessation medications include bupropion and varenicline. 104 A recent Canadian survey shows that pharmacist-led intervention resulted in more than 70% of patients using nicotine replacement therapy for smoking cessation. 105…”

Section: Cvd Preventionmentioning

confidence: 99%

Clinical pharmacists in chronic care

Mohiuddin¹

2020

SUJHS

View full text Add to dashboard Cite

Pharmacy practice has changed substantially in recent years. The professionals have the opportunity to contribute directly to patient care in order to reduce morbimortality related to medication use, promoting health and preventing diseases. Healthcare organizations worldwide are under substantial pressure from increasing patient demand. Unfortunately, a cure is not always possible particularly in this era of chronic diseases, and the role of physicians has become limited to controlling and palliating symptoms. The increasing population of patients with long-term conditions are associated with high levels of morbidity, healthcare costs and GP workloads. Clinical pharmacy took over an aspect of medical care that had been partially abandoned by physicians. Overburdened by patient loads and the explosion of new drugs, physicians turned to pharmacists more and more for drug information, especially within institutional settings. Once relegated to counting and pouring, pharmacists headed institutional reviews of drug utilization and served as consultants to all types of health-care facilities. In addition, when clinical pharmacists are active members of the care team, they enhance efficiency by: Providing critical input on medication use and dosing. Working with patients to solve problems with their medications and improve adherence.

show abstract

Clinical pharmacist’s role in implementing a smoking cessation intervention in a Swiss regional hospital: an exploratory study

Cited by 14 publications

References 21 publications

Tobacco related knowledge and support for smoke-free policies among community pharmacists in Lagos state, Nigeria

Tobacco related knowledge and support for smoke-free policies among community pharmacists in Lagos state, Nigeria

Impact of a Pilot, Pharmacy-Led Tobacco Cessation Medication Protocol at Discharge in a Community Hospital

Clinical pharmacists in chronic care

Contact Info

Product

Resources

About